ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 629 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 629; 2) Community: the network communities that were significantly associated with the response to NSC 629; 3) Molecule: the relationships between components within communities and NSC 629; 4) MDR: the compounds that were significantly associated with the NSC 629.

NSC Compound Enrichment Correlation
NSC 743909 1,5-bis(4-amidinophenoxy)-3-(4-toluenesulphonyl)-3-aza-pentane dihydrochloride 0.0105972823829604 0.2484129
NSC 620256 Platinate(2-), tetrachloro-, (SP-4-1), 9-hydroxy-2,5,11- trimethyl-6H-pyrido[4,3-b]carbazolium (1:2) 0.0108954273764103 0.31375744
NSC 642282 Null 0.0108954273764103 0.52500134
NSC 660027 Null 0.0108954273764103 0.46388661
NSC 681646 Camptothecin Derivative 0.0108954273764103 0.54131097
NSC 703329 Null 0.0108954273764103 0.35070458
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.0108954273764103 0.30109463
NSC 733504 Everolimus 0.0108954273764103 0.087313784
NSC 133115 1-(.beta.-D-Ribofuranosyl)-4-amino-2-pyridone 0.0138010872611484 -0.1666337
NSC 141545 Suavedol 0.0138010872611484 0.36457327
Total:43  Current:10    [First] [Prev] [Next] [Last]